Researcher Profiles

Return to member profile

Weichung (Joe) Shih, PhD

Publications since 2011

Song, M. DiPaola, R. S. Cracchiolo, B. M. Gibbon, D. G. Hellmann, M. Nieves-Neira, W. Vaidya, A. Wagreich, A. R. Shih, W. J. Rodriguez-Rodriguez, L. Phase 2 Trial of Paclitaxel, 13-cis Retinoic Acid, and Interferon Alfa-2b in the Treatment of Advanced Stage or Recurrent Cervical Cancer. Int J Gynecol Cancer, In process, . (PMID: 25304678)

Lu-Yao, G. L. Albertsen, P. C. Moore, D. F. Shih, W. Lin, Y. DiPaola, R. S. Yao, S. L. Fifteen-Year Survival Outcomes Following Primary Androgen-Deprivation Therapy for Localized Prostate Cancer. JAMA Intern Med, In process, . (PMID: 25023796)

Wu, Y. Lin, Y. Lu, S. E. Li, C. S. Shih, W. J. Extension of a Cox proportional hazards cure model when cure information is partially known. Biostatistics, 15:540-554, . (PMID: 24511081, PMCID: PMC4059463)

Ding, N. Cui, X. X. Gao, Z. Huang, H. Wei, X. Du, Z. Lin, Y. Shih, W. J. Rabson, A. B. Conney, A. H. Hu, C. Zheng, X. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors. Int J Oncol, 44:2139-2145, . (PMID: 24647860, PMCID: PMC4063540)

Chang, R. L. Wood, A. W. Huang, M. T. Xie, J. G. Cui, X. X. Reuhl, K. R. Boyd, D. R. Lin, Y. Shih, W. J. Balani, S. K. Yagi, H. Jerina, D. M. Conney, A. H. Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene. Carcinogenesis, 34:2184-2191, . (PMID: 23671133, PMCID: PMC3765047)

So, J. Y. Wahler, J. E. Yoon, T. Smolarek, A. K. Lin, Y. Shih, W. J. Maehr, H. Uskokovic, M. Liby, K. T. Sporn, M. B. Suh, N. Oral Administration of a Gemini Vitamin D Analog, a Synthetic Triterpenoid and the Combination Prevents Mammary Tumorigenesis Driven by ErbB2 Overexpression. Cancer Prev Res (Phila), 6:959-970, . (PMID: 23856074, PMCID: PMC3767182)

Shao, Y. H. Kim, S. Moore, D. F. Shih, W. Lin, Y. Stein, M. Kim, I. Y. Lu-Yao, G. L. Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score-Matched Analysis. Eur Urol, In process, . (PMID: 23759328)

Shao, Y. H. Moore, D. F. Shih, W. Lin, Y. Jang, T. L. Lu-Yao, G. L. Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications. BJU Int, 111:745-752, . (PMID: 23331464, PMCID: PMC3625488)

Kim, S. Moore, D. F. Shih, W. Lin, Y. Li, H. Shao, Y. H. Shen, S. Lu-Yao, G. L. Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer-How Long Does it Last? J Urol, 189:116-121, . (PMID: 23164376)

Lou, Y. Peng, Q. Li, T. Nolan, B. Bernard, J. J. Wagner, G. C. Lin, Y. Shih, W. J. Conney, A. H. Lu, Y. Oral Caffeine During Voluntary Exercise Markedly Inhibits Skin Carcinogenesis and Decreases Inflammatory Cytokines in UVB-Treated Mice. Nutr Cancer, 65:1002-1013, . (PMID: 24070239, PMCID: PMC3830615)

Little, R. J. Cohen, M. L. Dickersin, K. Emerson, S. S. Farrar, J. T. Neaton, J. D. Shih, W. Siegel, J. P. Stern, H. The design and conduct of clinical trials to limit missing data. Stat Med, 31:3433-3443, . (PMID: 22829439)

Lu-Yao, G. L. Albertsen, P. C. Li, H. Moore, D. F. Shih, W. Lin, Y. Dipaola, R. S. Yao, S. L. Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer? Eur Urol, 62:966-972, . (PMID: 22608160, PMCID: PMC3472155)

Smolarek, A. K. So, J. Y. Burgess, B. Kong, A. N. Reuhl, K. Lin, Y. Shih, W. J. Li, G. Lee, M. J. Chen, Y. K. Yang, C. S. Suh, N. Dietary Administration of delta- and gamma-Tocopherol Inhibits Tumorigenesis in the Animal Model of Estrogen Receptor-Positive, but not HER-2 Breast Cancer. Cancer Prev Res (Phila), 5:1310-1320, . (PMID: 22964476, PMCID: PMC3491089)

Little, R. J. D'Agostino, R. Cohen, M. L. Dickersin, K. Emerson, S. S. Farrar, J. T. Frangakis, C. Hogan, J. W. Molenberghs, G. Murphy, S. A. Neaton, J. D. Rotnitzky, A. Scharfstein, D. Shih, W. J. Siegel, J. P. Stern, H. The prevention and treatment of missing data in clinical trials. N Engl J Med, 367:1355-1360, . (PMID: 23034025, PMCID: PMC3771340)

Dong, G. Shih, W. J. Moore, D. Quan, H. Marcella, S. A Bayesian-frequentist two-stage single-arm phase II clinical trial design. Stat Med, 31:2055-2067, . (PMID: 22415966)

Quan, H. Li, M. Shih, W. J. Ouyang, S. P. Chen, J. Zhang, J. Zhao, P. L. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials. Stat Med, In process, . (PMID: 22855311)

Lu, Y. P. Lou, Y. R. Bernard, J. J. Peng, Q. Y. Li, T. Lin, Y. Shih, W. J. Nghiem, P. Shapses, S. Wagner, G. C. Conney, A. H. Surgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A, 109:9065-9070, . (PMID: 22615388, PMCID: PMC3384184)

Guan, F. Li, G. Liu, A. B. Lee, M. J. Yang, Z. Chen, Y. K. Lin, Y. Shih, W. Yang, C. S. delta- and gamma-tocopherols, but not alpha-tocopherol, inhibit colon carcinogenesis in azoxymethane-treated F344 rats. Cancer Prev Res (Phila), 5:644-654, . (PMID: 22366914, PMCID: PMC3324634)

Li, G. Lee, M. J. Liu, A. B. Yang, Z. Lin, Y. Shih, W. J. Yang, C. S. The antioxidant and anti-inflammatory activities of tocopherols are independent of Nrf2 in mice. Free Radic Biol Med, 52:1151-1158, . (PMID: 22226829)

Stein, M. Goodin, S. Doyle-Lindrud, S. Silberberg, J. Kane, M. Metzger, D. Eddy, S. Shih, W. DiPaola, R. S. Transdermal estradiol in castrate and chemotherapy resistant prostate cancer. Med Sci Monit, 18:CR260-CR264, . (PMID: 22460098)

Luo, X. Li, M. Shih, W. J. Ouyang, P. Estimation of treatment effect following a clinical trial with adaptive design. J Biopharm Stat, 22:700-718, . (PMID: 22651110)

Zheng, X. Cui, X. X. Huang, M. T. Liu, Y. Wagner, G. C. Lin, Y. Shih, W. J. Lee, M. J. Yang, C. S. Conney, A. H. Inhibition of Progression of Androgen-Dependent Prostate LNCaP Tumors to Androgen Independence in SCID Mice by Oral Caffeine and Voluntary Exercise. Nutr Cancer, 64:1029-1037, . (PMID: 23061906)

Shao, Y. H. Albertsen, P. C. Shih, W. Roberts, C. B. Lu-Yao, G. L. The impact of PSA testing frequency on prostate cancer incidence and treatment in older men. Prostate Cancer Prostatic Dis, 14:332-339, . (PMID: 21709691)

Kim, S. Shen, S. Moore, D. F. Shih, W. Lin, Y. Li, H. Dolan, M. Shao, Y. H. Lu-Yao, G. L. Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol, 60:908-916, . (PMID: 21684064, PMCID: PMC3185133)

Mehnert, J. M. Tan, A. R. Moss, R. Poplin, E. Stein, M. N. Sovak, M. Levinson, K. Lin, H. Kane, M. Gounder, M. Lin, Y. Shih, W. J. White, E. Rubin, E. H. Karantza, V. Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach. Mol Cancer Ther, 10:1509-1519, . (PMID: 21680752, PMCID: PMC3155243)

Lou, Y. R. Peng, Q. Y. Li, T. Medvecky, C. M. Lin, Y. Shih, W. J. Conney, A. H. Shapses, S. Wagner, G. C. Lu, Y. P. Effects of high fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis, 32:1078-1084, . (PMID: 21525235, PMCID: PMC3128560)

Albertsen, P. C. Moore, D. F. Shih, W. Lin, Y. Li, H. Lu-Yao, G. L. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol, 29:1335-1341, . (PMID: 21357791, PMCID: PMC3084001)

Li, G. X. Lee, M. J. Liu, A. B. Yang, Z. Lin, Y. Shih, W. J. Yang, C. S. delta-tocopherol is more active than alpha - or gamma -tocopherol in inhibiting lung tumorigenesis in vivo. Cancer Prev Res (Phila), 4:404-413, . (PMID: 21372040, PMCID: PMC3071153)

Zheng, X. Cui, X. X. Gao, Z. Zhao, Y. Shi, Y. Huang, M. T. Liu, Y. Wagner, G. C. Lin, Y. Shih, W. J. Rao, C. V. Yang, C. S. Conney, A. H. Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence. Exp Ther Med, 2:221-228, . (PMID: 21660218, PMCID: PMC3109910)